DUBLIN--()--Research and Markets(http://www.researchandmarkets.com/research/649b93/bayer_ag_in_consum) has announced the addition of the "Bayer AG in Consumer Health (World)" company profile to their offering.
Bayer's heritage lies in Aspirin, which the company developed in 1892. While new benefits continue to be found for the compound, Bayer has moved beyond the drug and become a leading player in vitamins and dietary supplements, as well as antifungals. The company continues to be overly reliant on the analgesics category, however, and sales of Aspirin have suffered with increased competition from private label alternatives, as well as other analgesic ingredients such as ibuprofen.
Euromonitor International's Bayer AG in Consumer Health (World) Company Profile offers detailed strategic analysis of the company's business, examining its performance in the Consumer Health industry. The report examines company shares by region and sector, product developments, market and distribution strategies, challenges from the competition and future prospects. Use it to understand opportunities and threats facing the business and the factors driving success.
Product coverage: Allergy Care, Child-Specific Consumer Health, Herbal/Traditional Products, OTC, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why Buy This Report?
- Get a detailed picture of the Consumer Health market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market's major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Key Topics Covered:
- Scope of the Report
- Strategic Evaluation
- Competitive Positioning
- Geographic Opportunities
- Product Opportunities
- Brand and Private Label Strategy
- Operations
- Recommendations
For more information visit http://www.researchandmarkets.com/research/649b93/bayer_ag_in_consum
Source: Euromonitor International

